BRPI0407174A - Regime de administração para nelfinavir - Google Patents
Regime de administração para nelfinavirInfo
- Publication number
- BRPI0407174A BRPI0407174A BR0407174-3A BRPI0407174A BRPI0407174A BR PI0407174 A BRPI0407174 A BR PI0407174A BR PI0407174 A BRPI0407174 A BR PI0407174A BR PI0407174 A BRPI0407174 A BR PI0407174A
- Authority
- BR
- Brazil
- Prior art keywords
- nelfinavir
- administration regimen
- mammal
- hiv
- administering
- Prior art date
Links
- QAGYKUNXZHXKMR-UHFFFAOYSA-N CPD000469186 Natural products CC1=C(O)C=CC=C1C(=O)NC(C(O)CN1C(CC2CCCCC2C1)C(=O)NC(C)(C)C)CSC1=CC=CC=C1 QAGYKUNXZHXKMR-UHFFFAOYSA-N 0.000 title abstract 4
- QAGYKUNXZHXKMR-HKWSIXNMSA-N nelfinavir Chemical compound CC1=C(O)C=CC=C1C(=O)N[C@H]([C@H](O)CN1[C@@H](C[C@@H]2CCCC[C@@H]2C1)C(=O)NC(C)(C)C)CSC1=CC=CC=C1 QAGYKUNXZHXKMR-HKWSIXNMSA-N 0.000 title abstract 4
- 229960000884 nelfinavir Drugs 0.000 title abstract 4
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"REGIME DE ADMINISTRAçãO PARA NELFINAVIR". A invenção refere-se a um método para tratar o vírus da imunodeficiência humana (HIV) em um mamífero, compreendendo a administração de uma quantidade terapeuticamente eficaz de nelfinavir, a um mamífero que necessite do mesmo, em uma composição farmacêutica, em que o nelfinavir é administrado com alimento.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44644403P | 2003-02-10 | 2003-02-10 | |
| US52425803P | 2003-11-21 | 2003-11-21 | |
| PCT/IB2004/000313 WO2004069251A1 (en) | 2003-02-10 | 2004-01-29 | Regimen of administration for nelfinavir |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0407174A true BRPI0407174A (pt) | 2006-02-07 |
Family
ID=32853430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0407174-3A BRPI0407174A (pt) | 2003-02-10 | 2004-01-29 | Regime de administração para nelfinavir |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1605942A1 (pt) |
| JP (1) | JP2006517221A (pt) |
| AR (1) | AR043133A1 (pt) |
| BR (1) | BRPI0407174A (pt) |
| CA (1) | CA2515095A1 (pt) |
| CL (1) | CL2004000202A1 (pt) |
| MX (1) | MXPA05008425A (pt) |
| NL (1) | NL1025449C2 (pt) |
| PA (1) | PA8595301A1 (pt) |
| PE (1) | PE20040948A1 (pt) |
| TW (1) | TW200423922A (pt) |
| UY (1) | UY28183A1 (pt) |
| WO (1) | WO2004069251A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7157455B2 (en) | 2003-02-10 | 2007-01-02 | Hoffmann-La Roche Inc. | 4-Aminopyrimidine-5-one derivatives |
-
2004
- 2004-01-29 JP JP2006502411A patent/JP2006517221A/ja active Pending
- 2004-01-29 MX MXPA05008425A patent/MXPA05008425A/es unknown
- 2004-01-29 WO PCT/IB2004/000313 patent/WO2004069251A1/en not_active Application Discontinuation
- 2004-01-29 CA CA002515095A patent/CA2515095A1/en not_active Abandoned
- 2004-01-29 BR BR0407174-3A patent/BRPI0407174A/pt not_active IP Right Cessation
- 2004-01-29 EP EP04706250A patent/EP1605942A1/en not_active Withdrawn
- 2004-02-05 CL CL200400202A patent/CL2004000202A1/es unknown
- 2004-02-09 TW TW093102921A patent/TW200423922A/zh unknown
- 2004-02-09 AR ARP040100399A patent/AR043133A1/es unknown
- 2004-02-09 PE PE2004000146A patent/PE20040948A1/es not_active Application Discontinuation
- 2004-02-09 PA PA20048595301A patent/PA8595301A1/es unknown
- 2004-02-10 UY UY28183A patent/UY28183A1/es not_active Application Discontinuation
- 2004-02-10 NL NL1025449A patent/NL1025449C2/nl not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1605942A1 (en) | 2005-12-21 |
| AR043133A1 (es) | 2005-07-20 |
| CL2004000202A1 (es) | 2005-03-18 |
| NL1025449A1 (nl) | 2004-08-12 |
| UY28183A1 (es) | 2004-09-30 |
| WO2004069251A1 (en) | 2004-08-19 |
| PA8595301A1 (es) | 2005-08-04 |
| JP2006517221A (ja) | 2006-07-20 |
| TW200423922A (en) | 2004-11-16 |
| CA2515095A1 (en) | 2004-08-19 |
| PE20040948A1 (es) | 2004-12-27 |
| NL1025449C2 (nl) | 2005-03-15 |
| MXPA05008425A (es) | 2005-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0513200A (pt) | uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas | |
| BR0009647A (pt) | Docetaxel em combinação com rhumab her2 para o tratamento de cânceres | |
| BRPI0410260A (pt) | composição conjugada para medicamento | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| BR0208563A (pt) | composições de n-acetilcisteìna e métodos para o tratamento e prevenção de toxidade de droga | |
| BR0316364A (pt) | Combinação de terapia do câncer com um composto anticâncer ativado com gst e uma outra terapia anticâncer | |
| RS52867B (en) | GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS | |
| ATE364595T1 (de) | Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika | |
| RU2010142456A (ru) | Синергические комбинации 5'-метилтиоаденозина | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| BRPI0409742A (pt) | uso de um agente anti-angiogênico, em combinação com um inibidor da famìlia src de tirosina quinases não-receptoras, produto de combinação, e, composição farmacêutica | |
| EA200501821A1 (ru) | Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат | |
| EA200970127A1 (ru) | Модулятор рецепторов глюкокортикостероидов и способы его применения | |
| BR0113165A (pt) | Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados | |
| ATE413187T1 (de) | Pharmazeutische zusammensetzungen mit interferon- tau | |
| BRPI0410761A (pt) | uso de leucina, e, composição para administração entérica a pacientes | |
| PT1220676E (pt) | Prevencao do cancro colorrectal | |
| BRPI0407174A (pt) | Regime de administração para nelfinavir | |
| BRPI0519023A2 (pt) | composiÇço farmacÊutica contendo pelo menos um derivado de dolastatina 10 | |
| BR112022008095A2 (pt) | Métodos e composições para o tratamento da síndrome de rett | |
| BR0316021A (pt) | Comibinação compreendendo um inibidor de cdk e cisplatina | |
| BRPI0509305A (pt) | uso de um sensibilizador insulìnico, composição farmecêutica, e , kit | |
| DOP2004000815A (es) | Metodo de tratamiento con nelfinavir | |
| GT200400014A (es) | Metodo de tratamiento con nelfinavir | |
| AR120453A1 (es) | Combinación de un inhibidor de btk y un inhibidor de mdm2 para el tratamiento del cáncer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE AS 4A, 5A, 6A, 7A E 8A ANUIDADES. |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |